Heal, that monitors wounds, delivers targeted therapy, and speeds up recovery by 25 per cent in preclinical trials.
Personalisation has long been the goal in FE. Yet, with diverse cohorts, rising workloads and pressure to demonstrate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback